ELF3 and prostate carcinoma: Further to this, stable expression of ELF3 in LNCaP and 22RV1 prostate cancer cells increased proliferation, colony formation, cell migration and resistance to anoikis in vitro, and promoted formation of lung metastases in vivo [41].